Literature DB >> 19747920

Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression.

Ali Esmaili1, Saad F Nazir, Alip Borthakur, Dan Yu, Jerrold R Turner, Seema Saksena, Amika Singla, Gail A Hecht, Waddah A Alrefai, Ravinder K Gill.   

Abstract

BACKGROUND & AIMS: Serotonin transporter (SERT) plays a critical role in regulating serotonin (5-hydroxytryptamine [5-HT]) availability in the gut. Elevated 5-HT levels are associated with diarrheal conditions such as irritable bowel syndrome and enteric infections. Whether alteration in SERT activity contributes to the pathophysiology of diarrhea induced by the food-borne pathogen enteropathogenic Escherichia coli (EPEC) is not known. The present studies examined the effects of EPEC infection on SERT activity and expression in intestinal epithelial cells and elucidated the underlying mechanisms.
METHODS: Caco-2 cells as a model of human intestinal epithelia and EPEC-infected C57BL/6J mouse model of infection were utilized. SERT activity was measured as Na(+) and Cl(-) dependent (3)[H] 5-HT uptake. SERT expression was measured by real-time quantitative reverse-transcription polymerase chain reaction, Western blotting, and immunofluorescence studies.
RESULTS: Infection of Caco-2 cells with EPEC for 30-120 minutes decreased apical SERT activity (P < .001) in a type 3 secretion system dependent manner and via involvement of protein tyrosine phosphatases. EPEC infection decreased V(max) of the transporter; whereas cell surface biotinylation studies revealed no alteration in the cellular or plasma membrane content of SERT in Caco-2 cells. EPEC infection of mice (24 hours) reduced SERT immunostaining with a corresponding decrease in SERT messenger RNA levels, 5-HT uptake, and mucosal 5-HT content in the small intestine.
CONCLUSIONS: Our results demonstrate inhibition of SERT by EPEC and define the mechanisms underlying these effects. These data may aid in the development of a novel pharmacotherapy to modulate the serotonergic system in treatment of infectious diarrheal diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747920      PMCID: PMC3727418          DOI: 10.1053/j.gastro.2009.09.002

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  57 in total

1.  Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits.

Authors:  J Miwa; H Echizen; K Matsueda; N Umeda
Journal:  Digestion       Date:  2001       Impact factor: 3.216

Review 2.  Biogenesis of the bundle-forming pilus of enteropathogenic Escherichia coli: reconstitution of fimbriae in recombinant E. coli and role of DsbA in pilin stability--a review.

Authors:  M S Donnenberg; H Z Zhang; K D Stone
Journal:  Gene       Date:  1997-06-11       Impact factor: 3.688

3.  A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12.

Authors:  T K McDaniel; J B Kaper
Journal:  Mol Microbiol       Date:  1997-01       Impact factor: 3.501

Review 4.  Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements.

Authors:  G Frankel; A D Phillips; I Rosenshine; G Dougan; J B Kaper; S Knutton
Journal:  Mol Microbiol       Date:  1998-12       Impact factor: 3.501

5.  A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium.

Authors:  K Kaniga; J Uralil; J B Bliska; J E Galán
Journal:  Mol Microbiol       Date:  1996-08       Impact factor: 3.501

6.  Intimin-dependent binding of enteropathogenic Escherichia coli to host cells triggers novel signaling events, including tyrosine phosphorylation of phospholipase C-gamma1.

Authors:  B Kenny; B B Finlay
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 7.  Interactions between enteropathogenic Escherichia coli and host epithelial cells.

Authors:  M S Donnenberg; J B Kaper; B B Finlay
Journal:  Trends Microbiol       Date:  1997-03       Impact factor: 17.079

8.  ATPase and phosphatase activity of Na+,K+-ATPase: molar and specific activity, protein determination.

Authors:  M Esmann
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

9.  Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception.

Authors:  J X Chen; H Pan; T P Rothman; P R Wade; M D Gershon
Journal:  Am J Physiol       Date:  1998-09

10.  Serotonin uptake and its modulation in rat jejunal enterocyte preparation.

Authors:  S Takayanagi; H Hanai; J Kumagai; E Kaneko
Journal:  J Pharmacol Exp Ther       Date:  1995-03       Impact factor: 4.030

View more
  37 in total

Review 1.  Mechanisms of diarrhea.

Authors:  Christina M Surawicz
Journal:  Curr Gastroenterol Rep       Date:  2010-08

2.  Epidermal growth factor upregulates serotonin transporter in human intestinal epithelial cells via transcriptional mechanisms.

Authors:  Ravinder K Gill; Arivarasu Natarajan Anbazhagan; Ali Esmaili; Anoop Kumar; Saad Nazir; Jaleh Malakooti; Waddah A Alrefai; Seema Saksena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-27       Impact factor: 4.052

3.  Enteropathogenic Escherichia coli inhibits ileal sodium-dependent bile acid transporter ASBT.

Authors:  Fadi Annaba; Zaheer Sarwar; Ravinder K Gill; Amit Ghosh; Seema Saksena; Alip Borthakur; Gail A Hecht; Pradeep K Dudeja; Waddah A Alrefai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

4.  The Serotonin Neurotransmitter Modulates Virulence of Enteric Pathogens.

Authors:  Aman Kumar; Regan M Russell; Reed Pifer; Zelia Menezes-Garcia; Santiago Cuesta; Sanjeev Narayanan; John B MacMillan; Vanessa Sperandio
Journal:  Cell Host Microbe       Date:  2020-06-09       Impact factor: 21.023

5.  Differences in gut microbiota composition of laying hen lines divergently selected on feather pecking.

Authors:  Jerine A J van der Eijk; Hugo de Vries; Joergen B Kjaer; Marc Naguib; Bas Kemp; Hauke Smidt; T Bas Rodenburg; Aart Lammers
Journal:  Poult Sci       Date:  2019-12-01       Impact factor: 3.352

Review 6.  Recent advances in small bowel diseases: Part I.

Authors:  Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

7.  Methods to Study Epithelial Transport Protein Function and Expression in Native Intestine and Caco-2 Cells Grown in 3D.

Authors:  Arivarasu N Anabazhagan; Ishita Chatterjee; Shubha Priyamvada; Anoop Kumar; Sangeeta Tyagi; Seema Saksena; Waddah A Alrefai; Pradeep K Dudeja; Ravinder K Gill
Journal:  J Vis Exp       Date:  2017-03-16       Impact factor: 1.355

Review 8.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 9.  Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.

Authors:  Gary M Mawe; Jill M Hoffman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-06-25       Impact factor: 46.802

Review 10.  Molecular mechanisms of Escherichia coli pathogenicity.

Authors:  Matthew A Croxen; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.